PDB Short entry for 2L7B HEADER LIPID TRANSPORT 07-DEC-10 2L7B TITLE NMR STRUCTURE OF FULL LENGTH APOE3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: APOLIPOPROTEIN E; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: APO-E; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: APOE; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET30A KEYWDS APOLIPOPROTEIN E, LIPID TRANSPORT, ATHEROSCLEROSIS, ALZHEIMER'S KEYWDS 2 DISEASE EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR J.CHEN,J.WANG REVDAT 2 21-SEP-11 2L7B 1 JRNL REVDAT 1 03-AUG-11 2L7B 0 JRNL AUTH J.CHEN,Q.LI,J.WANG JRNL TITL TOPOLOGY OF HUMAN APOLIPOPROTEIN E3 UNIQUELY REGULATES ITS JRNL TITL 2 DIVERSE BIOLOGICAL FUNCTIONS. JRNL REF PROC.NATL.ACAD.SCI.USA V. 108 14813 2011 JRNL REFN ISSN 0027-8424 JRNL PMID 21873229 JRNL DOI 10.1073/PNAS.1106420108 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PROCHECKNMR, CNS REMARK 3 AUTHORS : LASKOWSKI AND MACARTHUR (PROCHECKNMR), BRUNGER, REMARK 3 ADAMS, CLORE, GROS, NILGES AND READ (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2L7B COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-DEC-10. REMARK 100 THE RCSB ID CODE IS RCSB102046. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303 REMARK 210 PH : 6.9 REMARK 210 IONIC STRENGTH : 0.1 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1 MM [U-13C; U-15N; U-2H] APOE3, REMARK 210 100 MM SODIUM PHOSPHATE, 10 MM REMARK 210 DTT, 5 MM [U-100% 2H] EDTA, 1 MM REMARK 210 DSS, 90% H2O/10% D2O; 1 MM [U- REMARK 210 100% 13C; U-100% 15N; U-50% 2H] REMARK 210 APOE3, 10 MM DTT, 1 MM DSS, 5 MM REMARK 210 [U-100% 2H] EDTA, 100 MM SODIUM REMARK 210 PHOSPHATE, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D HNCA; 3D REMARK 210 HN(CO)CA; 3D HNCACB; 3D CBCA(CO) REMARK 210 NH; 3D 1H-15N NOESY; 4D CN NOESY; REMARK 210 3D HCCH-TOCSY; 3D CCC-TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : VNMR, NMRPIPE, TALOS, CYANA, REMARK 210 PIPP, NMRVIEW, PROCHECKNMR, CNS REMARK 210 METHOD USED : SIMULATED ANNEALING, DISTANCE REMARK 210 GEOMETRY REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 20 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : ALL CALCULATED STRUCTURES REMARK 210 SUBMITTED REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-20 REMARK 465 RES C SSSEQI REMARK 465 HIS A -7 REMARK 465 HIS A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 HIS A -1 REMARK 465 HIS A 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 VAL A 2 -37.12 -133.74 REMARK 500 1 GLU A 3 -36.71 -151.29 REMARK 500 1 GLU A 11 70.73 -114.37 REMARK 500 1 GLN A 24 -34.74 -178.31 REMARK 500 1 LEU A 43 -66.29 -173.74 REMARK 500 1 SER A 44 172.20 -54.93 REMARK 500 1 LEU A 82 -164.82 -128.70 REMARK 500 1 PRO A 84 75.32 -69.72 REMARK 500 1 VAL A 85 -73.69 -149.31 REMARK 500 1 ALA A 86 83.84 56.42 REMARK 500 1 GLU A 87 -65.62 -163.38 REMARK 500 1 GLU A 88 -40.50 -147.88 REMARK 500 1 MET A 125 -65.19 -97.99 REMARK 500 1 GLN A 128 -169.95 -116.26 REMARK 500 1 THR A 130 -38.70 -132.58 REMARK 500 1 ALA A 164 -81.52 -48.41 REMARK 500 1 ALA A 166 -169.35 -117.64 REMARK 500 1 ARG A 167 -77.14 -125.56 REMARK 500 1 LEU A 184 -168.12 -60.28 REMARK 500 1 GLU A 186 -72.27 70.75 REMARK 500 1 GLN A 201 74.49 -174.99 REMARK 500 1 LEU A 203 -74.58 -105.01 REMARK 500 1 GLN A 204 -45.63 -138.39 REMARK 500 1 GLU A 205 34.23 -179.62 REMARK 500 1 ARG A 206 19.80 -144.30 REMARK 500 1 GLN A 208 -69.23 -128.98 REMARK 500 1 ARG A 224 -32.31 179.18 REMARK 500 1 THR A 225 142.38 68.84 REMARK 500 1 ASP A 227 -63.75 -164.58 REMARK 500 1 ARG A 228 41.41 39.06 REMARK 500 1 LEU A 229 75.30 59.44 REMARK 500 1 GLU A 231 81.29 51.80 REMARK 500 1 VAL A 232 78.61 -150.95 REMARK 500 1 LEU A 268 -152.88 -153.66 REMARK 500 1 ALA A 269 30.56 -172.44 REMARK 500 1 ALA A 277 32.48 -144.10 REMARK 500 1 VAL A 280 -36.39 179.45 REMARK 500 1 GLU A 281 -31.32 175.99 REMARK 500 1 VAL A 283 72.50 49.90 REMARK 500 1 GLN A 284 93.81 -62.77 REMARK 500 1 ALA A 285 95.47 57.78 REMARK 500 1 ALA A 286 -171.59 52.16 REMARK 500 1 SER A 290 -65.47 -123.82 REMARK 500 1 ALA A 292 161.61 -48.83 REMARK 500 1 PRO A 293 85.01 -69.85 REMARK 500 1 SER A 296 -36.51 -164.68 REMARK 500 1 ASN A 298 -178.32 57.19 REMARK 500 2 GLU A 11 66.62 -116.69 REMARK 500 2 GLN A 24 -37.60 -179.17 REMARK 500 2 THR A 42 86.25 48.63 REMARK 500 REMARK 500 THIS ENTRY HAS 866 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 15744 RELATED DB: BMRB DBREF 2L7B A 1 299 UNP P02649 APOE_HUMAN 19 317 SEQADV 2L7B HIS A -7 UNP P02649 EXPRESSION TAG SEQADV 2L7B HIS A -6 UNP P02649 EXPRESSION TAG SEQADV 2L7B HIS A -5 UNP P02649 EXPRESSION TAG SEQADV 2L7B HIS A -4 UNP P02649 EXPRESSION TAG SEQADV 2L7B HIS A -3 UNP P02649 EXPRESSION TAG SEQADV 2L7B HIS A -2 UNP P02649 EXPRESSION TAG SEQADV 2L7B HIS A -1 UNP P02649 EXPRESSION TAG SEQADV 2L7B HIS A 0 UNP P02649 EXPRESSION TAG SEQADV 2L7B ALA A 257 UNP P02649 PHE 275 ENGINEERED MUTATION SEQADV 2L7B ARG A 264 UNP P02649 TRP 282 ENGINEERED MUTATION SEQADV 2L7B ALA A 269 UNP P02649 VAL 287 ENGINEERED MUTATION SEQADV 2L7B GLN A 279 UNP P02649 LEU 297 ENGINEERED MUTATION SEQADV 2L7B GLU A 287 UNP P02649 VAL 305 ENGINEERED MUTATION SEQRES 1 A 307 HIS HIS HIS HIS HIS HIS HIS HIS LYS VAL GLU GLN ALA SEQRES 2 A 307 VAL GLU THR GLU PRO GLU PRO GLU LEU ARG GLN GLN THR SEQRES 3 A 307 GLU TRP GLN SER GLY GLN ARG TRP GLU LEU ALA LEU GLY SEQRES 4 A 307 ARG PHE TRP ASP TYR LEU ARG TRP VAL GLN THR LEU SER SEQRES 5 A 307 GLU GLN VAL GLN GLU GLU LEU LEU SER SER GLN VAL THR SEQRES 6 A 307 GLN GLU LEU ARG ALA LEU MET ASP GLU THR MET LYS GLU SEQRES 7 A 307 LEU LYS ALA TYR LYS SER GLU LEU GLU GLU GLN LEU THR SEQRES 8 A 307 PRO VAL ALA GLU GLU THR ARG ALA ARG LEU SER LYS GLU SEQRES 9 A 307 LEU GLN ALA ALA GLN ALA ARG LEU GLY ALA ASP MET GLU SEQRES 10 A 307 ASP VAL CYS GLY ARG LEU VAL GLN TYR ARG GLY GLU VAL SEQRES 11 A 307 GLN ALA MET LEU GLY GLN SER THR GLU GLU LEU ARG VAL SEQRES 12 A 307 ARG LEU ALA SER HIS LEU ARG LYS LEU ARG LYS ARG LEU SEQRES 13 A 307 LEU ARG ASP ALA ASP ASP LEU GLN LYS ARG LEU ALA VAL SEQRES 14 A 307 TYR GLN ALA GLY ALA ARG GLU GLY ALA GLU ARG GLY LEU SEQRES 15 A 307 SER ALA ILE ARG GLU ARG LEU GLY PRO LEU VAL GLU GLN SEQRES 16 A 307 GLY ARG VAL ARG ALA ALA THR VAL GLY SER LEU ALA GLY SEQRES 17 A 307 GLN PRO LEU GLN GLU ARG ALA GLN ALA TRP GLY GLU ARG SEQRES 18 A 307 LEU ARG ALA ARG MET GLU GLU MET GLY SER ARG THR ARG SEQRES 19 A 307 ASP ARG LEU ASP GLU VAL LYS GLU GLN VAL ALA GLU VAL SEQRES 20 A 307 ARG ALA LYS LEU GLU GLU GLN ALA GLN GLN ILE ARG LEU SEQRES 21 A 307 GLN ALA GLU ALA ALA GLN ALA ARG LEU LYS SER ARG PHE SEQRES 22 A 307 GLU PRO LEU ALA GLU ASP MET GLN ARG GLN TRP ALA GLY SEQRES 23 A 307 GLN VAL GLU LYS VAL GLN ALA ALA GLU GLY THR SER ALA SEQRES 24 A 307 ALA PRO VAL PRO SER ASP ASN HIS HELIX 1 1 ALA A 5 GLU A 9 5 5 HELIX 2 2 PRO A 12 SER A 22 1 11 HELIX 3 3 GLN A 24 VAL A 40 1 17 HELIX 4 4 GLU A 45 LEU A 51 1 7 HELIX 5 5 SER A 54 GLU A 79 1 26 HELIX 6 6 THR A 89 LEU A 126 1 38 HELIX 7 7 THR A 130 GLN A 163 1 34 HELIX 8 8 GLU A 168 LEU A 181 1 14 HELIX 9 9 VAL A 190 GLY A 200 1 11 HELIX 10 10 ALA A 209 ARG A 224 1 16 HELIX 11 11 GLU A 238 GLU A 266 1 29 HELIX 12 12 GLU A 270 ALA A 277 1 8 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000